Főoldal / Kutatás / Herbert Irving Comprehensive Cancer Center Intézmény
Herbert Irving Comprehensive Cancer Center Más néven: Columbia University Herbert Irving Cancer Center · Columbia University Herbert Irving Comprehensive Cancer Center · HICCC
14 futó vizsgálat 10 lezárt vizsgálat 5248 publikáció (OpenAlex) Futó vizsgálatok Toboroz
Study of Adjuvant Darovasertib and Crizotinib in Participants With Primary Non-metastatic Uveal Melanoma
NCT07804186 · 3. fázis · IDEAYA Biosciences · Forrás
Toboroz
Neoadjuvant Darovasertib in Primary Uveal Melanoma
NCT07015190 · 3. fázis · IDEAYA Biosciences · Forrás
Toboroz
A Study to Assess the Safety, Tolerability, Efficacy, Pharmacokinetics, and Immunogenicity of Intravenous Administration of ARGX-119 in Pediatric Participants Aged 5 to Less Than 18 Years With Spinal Muscular Atrophy
NCT07287982 · 2. fázis · argenx · Forrás
Toboroz
A Multinational Study Assessing an Oral EGFR Inhibitor, DZD6008 in Patients Who Have Advanced NSCLC With EGFR Mutations (TIAN-SHAN1)
NCT06905197 · 1. fázis · Dizal Pharmaceuticals · Forrás
Fut, nem toboroz
Study to Assess the Efficacy of Rina-S Compared to Treatment of Investigator's Choice in Participants With Platinum Resistant Ovarian Cancer
NCT06619236 · 3. fázis · Genmab · Forrás
Fut, nem toboroz
A Basket Study of Customized Autologous TCR-T Cell Therapies in Patients With Locally Advanced (Unresectable) or Metastatic Solid Tumors
NCT05973487 · 1. fázis · TScan Therapeutics, Inc. · Forrás
Fut, nem toboroz
A Screening Study to Collect Samples for TAA, HLA & HLA Loss of Heterozygosity in Patients With Metastatic Solid Tumors
NCT05812027 · TScan Therapeutics, Inc. · Forrás
Toboroz
First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer
NCT05216432 · 1. fázis · Relay Therapeutics, Inc. · Forrás
Fut, nem toboroz
Safety and Efficacy Study of Epcoritamab in Subjects With Relapsed/Refractory Chronic Lymphocytic Leukemia and Richter's Syndrome
NCT04623541 · 1/2. fázis · Genmab · Forrás
Fut, nem toboroz
A Study to Assess the Efficacy, Safety, Pharmacodynamics, and Pharmacokinetics of Tazemetostat in Combination With Lenalidomide Plus Rituximab Versus Placebo in Combination With Lenalidomide Plus Rituximab in Adult Patients at Least 18 Years of Age With Relapsed/Refractory Follicular Lymphoma.
NCT04224493 · 3. fázis · Epizyme, Inc. · Forrás
Toboroz
Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
NCT04429542 · 1. fázis · Bicara Therapeutics · Forrás
Fut, nem toboroz
Study Assessing MTD, Safety, Tolerability, PK and Anti-tumor Effects of LNS8801alone and With Pembrolizumab
NCT04130516 · 1/2. fázis · Linnaeus Therapeutics, Inc. · Forrás
Fut, nem toboroz
Safety and Efficacy of Pembrolizumab (MK-3475) in Children and Young Adults With Classical Hodgkin Lymphoma (MK-3475-667/KEYNOTE-667)
NCT03407144 · 2. fázis · Merck Sharp & Dohme LLC · Forrás
Fut, nem toboroz
Lung-MAP: Nivolumab With or Without Ipilimumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching Biomarkers
NCT02785952 · 3. fázis · SWOG Cancer Research Network · Forrás
Egyszerre toboroz Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.
Regiszterbeli névváltozatok (6) Mind mutatása Elrejtés A vizsgálati regiszterek ezeken a neveken tartják nyilván az intézményt. Minden sor egy regiszterbejegyzés: a címe és az alatta nyilvántartott vizsgálatok.
Columbia University / Herbert Irving Comprehensive Cancer Center
New York, New York 10032
14 vizsgálat
Herbert Irving Comprehensive Cancer Center
New York, New York 10032
4 vizsgálat
Columbia University/Herbert Irving Cancer Center
New York, New York 10032
3 vizsgálat
Columbia U - Herbert Irving Comprehensive Cancer Center
New York, New York 10032
1 vizsgálat
Columbia University/Herbert Irving Cancer Center (Site 0009)
New York, New York 10032
1 vizsgálat
Columbia University/Herbert Irving Cancer Center (Site 0063)
New York, New York 10032
1 vizsgálat
Hibát jelzek